Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States...

by Kunchok Dorjee, Sanjiv M. Baxi, Arthur L. Reingold, Alan Hubbard
Published 2017-10-01

Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States

by Kunchok Dorjee, Manisha Desai, Tsering Choden, Sanjiv M. Baxi, Alan E. Hubbard, Arthur L. Reingold
Published 2021-09-01

Indoor residual spraying of insecticide and malaria morbidity in a high transmission intensity area of Uganda.

by Ruth Kigozi, Sanjiv M Baxi, Anne Gasasira, Asadu Sserwanga, Stella Kakeeto, Sussann Nasr, Denis Rubahika, Gunawardena Dissanayake, Moses R Kamya, Scott Filler, Grant Dorsey
Published 2012-01-01

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial.

by Sanjiv M Baxi, Eric Vittinghoff, Peter Bacchetti, Yong Huang, Kata Chillag, Ryan Wiegand, Peter L Anderson, Robert Grant, Ruth M Greenblatt, Susan Buchbinder, Monica Gandhi, Albert Y Liu
Published 2018-01-01

Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients.

by Sanjiv M Baxi, Ruth M Greenblatt, Peter Bacchetti, Chengshi Jin, Audrey L French, Marla J Keller, Michael H Augenbraun, Stephen J Gange, Chenglong Liu, Wendy J Mack, Monica Gandhi, Women’s Interagency HIV Study (WIHS)
Published 2015-01-01